Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bonacorsi

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2006
Escherichia coli native valve endocarditisR Micol, O Lortholary, F Jaureguy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2007
Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsisF Jauréguy, E Carbonnelle, S Bonacorsi, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 21, 2009
[Streptococcus pyogenes or group A streptococcal infections in child: French national reference center data]P Bidet, C Plainvert, C Doit, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Mechanisms of macrolide resistance in clinical group B streptococci isolated in FranceF Fitoussi, C Loukil, I Gros, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 10, 2007
Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalitiesV Houdouin, S Bonacorsi, F Mahjoub-Messai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2000
Metabolism of [(14)C]omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humansR A Iyer, J Mitroka, B Malhotra, et al.
Medecine Et Maladies Infectieuses|October 22, 2017
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infectionM Bruyand, P Mariani-Kurkdjian, M Gouali, et al.
The Journal of Hospital Infection|October 1, 2022
Epidemiological investigation of Pseudomonas aeruginosa isolates including multidrug-resistant serogroup O12 isolates, by use of a rapid and simplified multiple-locus variable-number of tandem repeats analysis and whole genome sequencingP Bidet, A Birgy, B Brethon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 13, 2018
Prevalence of Kingella kingae oropharyngeal carriage and predominance of type a and type b polysaccharide capsules among French young childrenR Basmaci, K Deschamps, C Levy, et al.
Jac-Antimicrobial Resistance|July 7, 2022
MiniBioReactor Array (MBRA) <i>in vitro</i> gut model: a reliable system to study microbiota-dependent response to antibiotic treatmentC A Hobson, L Vigue, S Naimi, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2006
Escherichia coli native valve endocarditisR Micol, O Lortholary, F Jaureguy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2007
Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsisF Jauréguy, E Carbonnelle, S Bonacorsi, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 21, 2009
[Streptococcus pyogenes or group A streptococcal infections in child: French national reference center data]P Bidet, C Plainvert, C Doit, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Mechanisms of macrolide resistance in clinical group B streptococci isolated in FranceF Fitoussi, C Loukil, I Gros, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 10, 2007
Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalitiesV Houdouin, S Bonacorsi, F Mahjoub-Messai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2000
Metabolism of [(14)C]omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humansR A Iyer, J Mitroka, B Malhotra, et al.
Medecine Et Maladies Infectieuses|October 22, 2017
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infectionM Bruyand, P Mariani-Kurkdjian, M Gouali, et al.
The Journal of Hospital Infection|October 1, 2022
Epidemiological investigation of Pseudomonas aeruginosa isolates including multidrug-resistant serogroup O12 isolates, by use of a rapid and simplified multiple-locus variable-number of tandem repeats analysis and whole genome sequencingP Bidet, A Birgy, B Brethon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 13, 2018
Prevalence of Kingella kingae oropharyngeal carriage and predominance of type a and type b polysaccharide capsules among French young childrenR Basmaci, K Deschamps, C Levy, et al.
Jac-Antimicrobial Resistance|July 7, 2022
MiniBioReactor Array (MBRA) <i>in vitro</i> gut model: a reliable system to study microbiota-dependent response to antibiotic treatmentC A Hobson, L Vigue, S Naimi, et al.
Pageof 6